TREATMENT METHODS FOR CROHN'S DISEASE WITH A SPECIFIC ANTI-IL23 ANTIBODY

MA67019B1Active Publication Date: 2026-06-30JANSSEN BIOTECH INC
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
MA · MA
Patent Type
Patents
Current Assignee / Owner
JANSSEN BIOTECH INC
Filing Date
2022-10-27
Publication Date
2026-06-30
Patent Text Reader

Abstract

The invention relates to a method of treating Crohn's disease in a patient by administering a specific IL-23 antibody, for example, guselkumab, at an initial subcutaneous dose and subsequent subcutaneous doses so that the patient responds to the antibody and so as to meet one or more clinical outcome indicators.
Need to check novelty before this filing date? Find Prior Art